Hospice Eligibility Criteria: How Medicare Determines Who Qualifies for Hospice

Hospice eligibility comes down to one certified judgment: a physician's determination that the patient's life expectancy is six months or less if the terminal illness runs its normal course. There is no CMS list of approved diagnoses — any terminal condition qualifies. What governs eligibility is severity, documented decline, and clinical evidence supporting that six-month prognosis, not the diagnosis code itself.

That single sentence resolves most of the confusion around hospice eligibility. The rest of this guide is what stands behind it: how certification works across benefit periods, what clinical indicators support the prognosis for each major diagnosis, and — the part that determines whether a claim survives review — what has to actually appear in the chart.

Quick answers

What are the eligibility criteria for hospice?A physician must certify a life expectancy of six months or less if the illness runs its normal course. Eligibility is supported by documented functional decline, disease-specific clinical indicators, and a physician narrative explaining the prognosis. Medicare hospice is available to beneficiaries who elect the benefit and forgo curative treatment for the terminal illness.

Is there a list of qualifying hospice diagnoses?No. CMS does not publish an approved-diagnosis list. Any terminal illness qualifies if the six-month prognosis is certified and documented. Certain diagnoses — dementia, COPD, heart failure, cancer — have published clinical indicators (LCDs) that help support the prognosis, but the diagnosis itself is never the deciding factor.

Does a patient lose eligibility if they live longer than six months?No. Prognostication is inexact, and CMS is explicit that outliving a prognosis is not, by itself, grounds for discharge. As long as the patient continues to show a reasonable expectation of a six-month prognosis, they remain eligible — across an unlimited number of benefit periods.

What happens if a patient stabilizes on hospice?Stabilization alone is not disqualifying. If continued decline consistent with a six-month prognosis remains reasonably expected, the patient stays eligible. Only when improvement is expected to continue outside the hospice setting is discharge indicated. This distinction lives entirely in the documentation.

Who certifies hospice eligibility?For the first benefit period, both the hospice medical director (or an IDG physician) and the patient's attending physician must certify. For subsequent periods, the hospice physician alone certifies. From the third period onward, a face-to-face encounter is also required.

What's the single most important piece of documentation?Functional performance scores (PPS or KPS) recorded at every certification and compared over time. A declining trajectory is the strongest evidence a six-month prognosis is defensible.

The core standard: a certified six-month prognosis

Medicare coverage of hospice depends on a physician's certification that the individual's prognosis is a life expectancy of six months or less if the terminal illness runs its normal course. This is the governing standard, and everything else is in service of documenting it.

Two consequences follow that trip up agencies repeatedly:

Living past six months is not a discharge trigger. The benefit is structured around an unlimited number of periods precisely because predicting life expectancy is imprecise. A patient who remains appropriate can be recertified indefinitely.

Stabilizing is not automatically disqualifying. A patient whose condition stabilizes but who retains a reasonable expectation of continued decline remains eligible. The moment that expectation no longer holds — when improvement is likely to continue outside hospice — is the moment for discharge. Because both states can look similar in a chart, the narrative that distinguishes them is what a reviewer relies on.

For the full framework on writing that narrative, see how to write a hospice eligibility narrative that survives audit.

Certification by benefit period

Mechanical certification errors cause denials that have nothing to do with whether the patient was eligible. The structure:

Every certification must contain:

• A statement that life expectancy is six months or less if the illness runs its normal course
• Specific clinical findings supporting that prognosis
• A brief narrative composed by the certifying physician
• A physician attestation confirming they wrote the narrative from record review or examination
• Signatures, date signed, and the benefit period dates covered

A certification missing the physician's narrative is completed as an insufficient documentation error, and the MAC recoups payment — regardless of eligibility. Since June 2024, the certifying physician must also be enrolled in or validly opted out of Medicare for the claim to pay.

From the third period onward, the recertification narrative must explain how the face-to-face findings support the six-month prognosis — not merely that the encounter occurred. This is a specific, frequently-missed requirement covered in depth in the guide to the hospice face-to-face encounter.

Functional decline: the shared backbone

Across nearly every diagnosis, Medicare Administrative Contractors look for objective functional measurement. Two scales carry most of the weight:

• Palliative Performance Scale (PPS) — 70% or below generally supports eligibility
• Karnofsky Performance Status (KPS) — below 70% likewise
• For stroke and coma, the threshold is stricter: below 40%

The highest-value documentation habit in hospice is recording these scores at every certification and comparing them over time. A PPS of 50% is a data point. A PPS that moved 70 → 60 → 50 across three periods is a trajectory — and a trajectory is what makes a six-month prognosis defensible.

Supporting decline indicators reviewers weight:

• Unintentional weight loss greater than 10% over six months
• Serum albumin below 2.5 g/dL
• Declining mid-arm circumference or BMI
• Increasing dependence in activities of daily living
• Recurrent hospitalizations or emergency department visits
• Progressive stage 3–4 pressure ulcers despite intervention
• Dysphagia leading to inadequate intake or recurrent aspiration

Eligibility indicators by diagnosis

Medicare Administrative Contractors publish Local Coverage Determinations — principally L34538 and L33393 — that spell out diagnosis-specific clinical indicators.

The most important thing to understand about them: meeting a guideline is not automatic qualification, and missing one is not automatic denial. The LCDs give the certifying physician objective evidence to support clinical judgment. Clinical judgment governs. A patient may match a guideline and still not be terminal; a patient may miss every guideline and still be clearly dying. Document accordingly.

Dementia and Alzheimer's

The most-searched and most-misapplied category. Baseline: FAST stage 7a or beyond — speech limited to a handful of intelligible words, non-ambulatory, dependent for dressing and bathing, incontinent. Because the FAST scale is sequential, a patient who skipped stages due to an unrelated condition needs a narrative explanation rather than a stage number. Beyond 7a, at least one qualifying comorbidity in the prior 12 months (aspiration pneumonia, upper UTI, septicemia, multiple stage 3–4 ulcers, recurrent post-antibiotic fever, or inadequate intake with significant weight loss).

Full detail: hospice eligibility for dementia and Alzheimer's, and how the FAST scale is applied for hospice eligibility.

COPD

Disabling dyspnea at rest poorly responsive to bronchodilators, documented disease progression, hypoxemia or hypercapnia on room air, and often cor pulmonale or significant unintentional weight loss. FEV₁ is supportive but not required. Full detail: hospice eligibility for COPD.

Heart disease

NYHA Class IV — symptoms at rest, optimally treated or intolerant of treatment — with an ejection fraction of 20% or below as supportive evidence. Full detail: hospice eligibility for heart failure.

Cancer

Metastatic or widespread disease with documented progression, PPS at or below 70%, and continued decline despite therapy or an informed decision to forgo curative treatment. Cancer certifications are often the most weakly documented, because eligibility feels self-evident — reviewers still need the functional scores and progression evidence written down.

The narrative is where cases are won and lost

Every clinical element can be present and the claim can still fail, because the narrative is the only place a reviewer encounters the physician's actual reasoning. Three failure patterns account for most denials:

• Restating the diagnosis. "End-stage COPD with a prognosis under six months" is a conclusion, not a justification.
• Copying the prior period. An identical paragraph across recertifications tells the reviewer the patient hasn't declined — an argument against continued eligibility, made in your own words.
• Omitting the comparison. "PPS 40%" is weaker than "PPS declined from 60% to 40% since the prior certification, with new dependence in transfers and a 14-pound weight loss."

The pattern that works: specific findings, compared against the prior period, connected explicitly to the prognosis. See annotated recertification narrative examples for side-by-side passing and failing versions.

What changed for 2026

HOPE replaced HIS. The Hospice Outcomes and Patient Evaluation tool introduced interview-based assessment and timed data-collection points. See the HOPE tool overview, the HOPE Update Visit timepoints, and the HIS-to-HOPE transition.

The FY 2026 final rule adjusted rates and the aggregate cap — now $35,361.44 per beneficiary. Weak narratives on long-stay patients are exactly what turn a cap liability into a recoupment; see the full FY 2026 rule summary.

Program integrity scrutiny increased, with the Hospice Special Focus Program signaling higher documentation-review volume ahead.

When an ADR arrives

An Additional Documentation Request is where all of this becomes concrete. The essentials: send the complete certification packet for every period under review, include the clinical evidence each narrative references, sequence documents so decline is visible chronologically, address thin narratives directly with a cover summary, and track the deadline — late is denied regardless of merit. Full walkthrough: how to respond to a hospice ADR. And because timing failures are pure administrative losses, re-read the five-day NOE filing rule.

Reviewing charts for eligibility with AI

Chart review for eligibility — reading hundreds of pages, extracting functional scores across time, drafting a narrative that compares this period to the last — is exactly the kind of work AI does well. The obstacle is that hospice charts are dense PHI, and the obvious tools aren't covered.

Pasting a chart into a consumer AI assistant is a HIPAA violation on the first message; the consumer tiers of every major assistant sit outside any Business Associate Agreement. See the specific risks of using ChatGPT for hospice documentation.

The workable version requires a signed BAA covering the surface you're using. Hathr.AI runs Anthropic's Claude inside AWS GovCloud — a FedRAMP High environment — with a BAA on every account and zero data retention, so a full chart can be uploaded and reviewed without leaving a compliant boundary. See how it works, or start a trial.

Get the checklist

Everything above, condensed into a 3-page reference your team can print and keep at the desk — certification by benefit period, LCD indicators by diagnosis, the narrative quality check, and the ADR packet list.

Download the free Hospice Eligibility Checklist →

Explore the hospice documentation library

Eligibility & certification — Eligibility narrative · Recertification examples · Face-to-face encounter · Checklist

HOPE & quality reporting — HOPE tool · HUV timepoints · HIS-to-HOPE

Billing, audit & compliance — ADR response · NOE filing · Cap calculation · FY 2026 rule · Special Focus Program

This guide summarizes publicly available CMS guidance and Local Coverage Determinations as of publication. LCD criteria vary by Medicare Administrative Contractor and are revised periodically. It is not clinical or legal advice — verify current requirements with your MAC and compliance counsel, and defer to the certifying physician's clinical judgment in all cases.